Glenmark Pharmaceuticals receives USFDA tentative nod for anti-asthma tablets – Economic Times


Moneycontrol.com

Glenmark Pharmaceuticals receives USFDA tentative nod for anti-asthma tablets
Economic Times
NEW DELHI: Glenmark Pharmaceuticals today said it has received tentative approval from the US health regulator to market its generic Montelukast Sodium tablets used for treating asthma and seasonal allergies. Glenmark Generics Inc has received
Glenmark gets tentative US FDA nod for asthma drugMoneycontrol.com
Glenmark Generics gets Tentative USFDA nod for Montelukast Sodium 10 mg tabletsEquity Bulls

all 2 news articles »

View full post on asthma – Google News

Glenmark starts Phase-IIb human trials of Revamilast molecule – Economic Times

Glenmark starts Phase-IIb human trials of Revamilast molecule
Economic Times
NEW DELHI: Glenmark Pharmaceuticals on Wednesday said it has started Phase-IIb human trials of its 'Revamilast' molecule, which is being developed for treatment of inflammatory disorders like asthma and rheumatoid arthritis. The Phase-IIb studies of
Glenmark initiates Phase IIb human trials globally for its novel molecule India Infoline.com

all 7 news articles »

View full post on asthma – Google News